Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohortsSiri H. Strand, Graham A. Colditz, Lorraine King et al.|Cancer Cell|2022Cited by 88
Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomasInga‐Marie Schaefer, Jonathan A. Fletcher, Meijun Z. Lundberg et al.|Cancer|2021Cited by 35